MedTrace Logo

Pedagogical Aspects on Training in Basic Life Support

NCT03618888 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 2623

Last updated 2020-03-27

No results posted yet for this study

Summary

Cardio vascular disease (CVD) including out-of-hospital cardiac arrest (OHCA) is still the leading cause of death in a global perspective. Start of cardiopulmonary resuscitation (CPR) with automated external defibrillator (AED) may double or quadruple survival. Scientific research on education in Basic Life Support (BLS) in the society is active in different part of Europe but low in Sweden. The aim of this study is to investigate the effectiveness and retention after different training interventions in BLS and willingness to act in a real-life cardiac arrest situation in the society of Sweden, based on European Resuscitation Council (ERC) guidelines. This is an experimental cluster randomized trial, including participants from a BLS education project in Sweden.

Conditions

  • Basic Life Support

Interventions

OTHER

Instructor-led training

The Instructor-led training contents a supervised practical training with a standard kit for training in BLS

OTHER

Self-learning training

The self-learning training contents a standard kit for self-directed training in BLS

Sponsors & Collaborators

  • Swedish Heart Lung Foundation

    collaborator OTHER

  • University of Boras

    lead OTHER

Principal Investigators

  • Johan D Herlitz, Professor · University of Borås Sweden

Study Design

Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2014-03-01
Primary Completion
2016-12-31
Completion
2019-12-31

Countries

  • Sweden

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03618888 on ClinicalTrials.gov